CP-100356 HCl (CP100356), the hydrochloride salt of CP-100356, is a novel and potent affinity P-glycoprotein (P-gp) inhibitor, inhibiting protypical ABC transporter.
Physicochemical Properties
| Molecular Formula | C31H37CLN4O6 |
| Molecular Weight | 597.109 |
| Exact Mass | 596.24 |
| CAS # | 142715-48-8 |
| Related CAS # | 142716-85-6;142715-48-8(HCl); |
| PubChem CID | 71312025 |
| Appearance | White to off-white solid powder |
| LogP | 5.187 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 11 |
| Heavy Atom Count | 42 |
| Complexity | 796 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | WWCHXVYTCMPAMV-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C31H36N4O6.ClH/c1-36-24-8-7-19(13-25(24)37-2)9-11-32-31-33-23-17-29(41-6)28(40-5)16-22(23)30(34-31)35-12-10-20-14-26(38-3)27(39-4)15-21(20)18-35;/h7-8,13-17H,9-12,18H2,1-6H3,(H,32,33,34);1H |
| Chemical Name | 4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-N-(3,4-dimethoxyphenethyl)-6,7-dimethoxyquinazolin-2-amine hydrochloride |
| Synonyms | CP-100356 HClCP 100356 CP-100356CP100356 CP-100356 hydrochloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | In human MDR1-transfected MDCKII cells, CP-100356 hydrochloride (0.1-15 μM; only 30 minutes) inhibits the transport of digoxin and calcein-AM solution, with an IC50 of 0.50 μM and digoxin, respectively. CP-100356 hydrochloride (0.064–200 μM; 5 min) suppresses the toxin estrogen 17β 1.2 μM that is mediated by OATP1B1. In investigations of equilibrium inhibition using CP-100356 Hydrochloride (0-50 μM; 10-30 minutes) -D-aldehyde acid solution, the enzymatic activity of monomeric P450 inside P4503A4 is inhibited (IC50 = approximately 66 μM). No inhibition (IC50>50 μM) is observed[1]. |
| ln Vivo | CP-100356 Systemic exposure to fexofenadine at higher dosages (increases in Cmax and AUC at 24 mg/kg of 36 and 80 times, respectively) [1]. |
| References |
[1]. N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a "chemical knock-out equivalent" to assess the impact of efflux transporters on oral drug absorption in the rat. J Pharm Sci. 2009 Dec;98(12):4914-27. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~11.36 mg/mL (~19.03 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.14 mg/mL (1.91 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 11.4 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.14 mg/mL (1.91 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 11.4 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 1.14 mg/mL (1.91 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 11.4 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.6747 mL | 8.3737 mL | 16.7473 mL | |
| 5 mM | 0.3349 mL | 1.6747 mL | 3.3495 mL | |
| 10 mM | 0.1675 mL | 0.8374 mL | 1.6747 mL |